Rankin and her team focused on a a specific type of neurodegenerative disease called frontotemporal dementia, or FTD, a group of disorders in which patients can experience behavioral symptoms such as personality changes, a loss of inhibition and social tact as well as language difficulties, such as an inability to understand words.